Lebwohl David

EDGAR CIK 0001810882

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($109,627)
-11,903 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/05/2026
01/07/2026
Sell
-11,903 @ $9.21
 ($109,627) 121,249 (-8.94%) Direct